Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15729385rdf:typepubmed:Citationlld:pubmed
pubmed-article:15729385lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:15729385lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:15729385lifeskim:mentionsumls-concept:C0080090lld:lifeskim
pubmed-article:15729385lifeskim:mentionsumls-concept:C0023480lld:lifeskim
pubmed-article:15729385lifeskim:mentionsumls-concept:C0026882lld:lifeskim
pubmed-article:15729385lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:15729385lifeskim:mentionsumls-concept:C1853118lld:lifeskim
pubmed-article:15729385lifeskim:mentionsumls-concept:C0205217lld:lifeskim
pubmed-article:15729385lifeskim:mentionsumls-concept:C0439661lld:lifeskim
pubmed-article:15729385lifeskim:mentionsumls-concept:C1514485lld:lifeskim
pubmed-article:15729385pubmed:issue4lld:pubmed
pubmed-article:15729385pubmed:dateCreated2005-4-29lld:pubmed
pubmed-article:15729385pubmed:abstractTextSevere congenital neutropenia (CN) is characterized by a maturation arrest of myelopoiesis at the promyelocyte stage. Treatment with pharmacological doses of recombinant human granulocyte colony-stimulating factor (rh-G-CSF) stimulates neutrophil production and decreases the risk of major infectious complications. However, approximately 15% of CN patients develop myeloid malignancies that have been associated with somatic mutations in the G-CSF receptor (G-CSFR) and RAS genes as well as with acquired monosomy 7. We report a CN patient with chronic myelomonocytic leukemia (CMML) who never received rh-G-CSF. Molecular analysis demonstrated a somatic G-CSFR mutation (C2390T), which led to expression of a truncated G-CSFR protein in the CMML. Normal G-CSFR expression was unexpectedly absent in primary and cultured CMML. In addition, CMML cells showed monosomy 7 and an oncogenic NRAS mutation. In vitro culture revealed a G-CSF-dependent proliferation of CMML cells, which subsequently differentiated along the monocytic/macrophage lineage. Our results provide direct evidence for the in vivo expression of a truncated G-CSFR in leukemic cells, which emerged in the absence of rh-G-CSF treatment and transduces proliferative signals.lld:pubmed
pubmed-article:15729385pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15729385pubmed:languageenglld:pubmed
pubmed-article:15729385pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15729385pubmed:citationSubsetIMlld:pubmed
pubmed-article:15729385pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15729385pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15729385pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15729385pubmed:statusMEDLINElld:pubmed
pubmed-article:15729385pubmed:monthAprlld:pubmed
pubmed-article:15729385pubmed:issn0887-6924lld:pubmed
pubmed-article:15729385pubmed:authorpubmed-author:ShannonKKlld:pubmed
pubmed-article:15729385pubmed:authorpubmed-author:SchulzeHHlld:pubmed
pubmed-article:15729385pubmed:authorpubmed-author:WelteKKlld:pubmed
pubmed-article:15729385pubmed:authorpubmed-author:KratzCClld:pubmed
pubmed-article:15729385pubmed:authorpubmed-author:ReppRRlld:pubmed
pubmed-article:15729385pubmed:authorpubmed-author:WilkensLLlld:pubmed
pubmed-article:15729385pubmed:authorpubmed-author:BallmaierMMlld:pubmed
pubmed-article:15729385pubmed:authorpubmed-author:GermeshausenM...lld:pubmed
pubmed-article:15729385pubmed:issnTypePrintlld:pubmed
pubmed-article:15729385pubmed:volume19lld:pubmed
pubmed-article:15729385pubmed:ownerNLMlld:pubmed
pubmed-article:15729385pubmed:authorsCompleteYlld:pubmed
pubmed-article:15729385pubmed:pagination611-7lld:pubmed
pubmed-article:15729385pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:15729385pubmed:meshHeadingpubmed-meshheading:15729385...lld:pubmed
pubmed-article:15729385pubmed:meshHeadingpubmed-meshheading:15729385...lld:pubmed
pubmed-article:15729385pubmed:meshHeadingpubmed-meshheading:15729385...lld:pubmed
pubmed-article:15729385pubmed:meshHeadingpubmed-meshheading:15729385...lld:pubmed
pubmed-article:15729385pubmed:meshHeadingpubmed-meshheading:15729385...lld:pubmed
pubmed-article:15729385pubmed:meshHeadingpubmed-meshheading:15729385...lld:pubmed
pubmed-article:15729385pubmed:meshHeadingpubmed-meshheading:15729385...lld:pubmed
pubmed-article:15729385pubmed:meshHeadingpubmed-meshheading:15729385...lld:pubmed
pubmed-article:15729385pubmed:meshHeadingpubmed-meshheading:15729385...lld:pubmed
pubmed-article:15729385pubmed:meshHeadingpubmed-meshheading:15729385...lld:pubmed
pubmed-article:15729385pubmed:meshHeadingpubmed-meshheading:15729385...lld:pubmed
pubmed-article:15729385pubmed:year2005lld:pubmed
pubmed-article:15729385pubmed:articleTitleAn acquired G-CSF receptor mutation results in increased proliferation of CMML cells from a patient with severe congenital neutropenia.lld:pubmed
pubmed-article:15729385pubmed:affiliationDepartment of Pediatric Hematology and Oncology, Hannover Medical School, Germany. Germeshausen.Manuela@mh-hannover.delld:pubmed
pubmed-article:15729385pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15729385pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:15729385pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:15729385pubmed:publicationTypeCase Reportslld:pubmed
pubmed-article:15729385pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15729385lld:pubmed